Boston-based start-up a2z Radiology AI has received clearance from the U.S. Food and Drug Administration (FDA) for an algorithm that can flag seven urgent findings on abdominal/pelvic CT scans simultaneously.
Called a2z-Unified-Triage, the device covers seven major acute conditions in a single integration: small bowel obstruction, acute cholecystitis, acute pancreatitis, acute diverticulitis, hydronephrosis, free air, and unruptured abdominal aortic aneurysm.
Abdominal/pelvic CT is the highest-volume CT category in the U.S., with over 20 million exams annually, a2z Radiology noted.
“a2z-Unified-Triage works to flag suspected emergencies and move them to the top of the worklist in minutes to ensure faster care for critical patients,” said the company’s co-founder, Pranav Rajpurkar, PhD, in a news release. Rajpurkar is an associate professor of biomedical informatics at Harvard University.
